🇺🇸 FDA
Patent

US 11478541

Method for inactivating Zika virus and for determining the completeness of inactivation

granted A61KA61K2039/5252A61K2039/54

Quick answer

US patent 11478541 (Method for inactivating Zika virus and for determining the completeness of inactivation) held by Takeda Vaccines, Inc. expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/5252, A61K2039/54, A61K2039/545, A61K2039/55505